StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Integrated BioPharma

Integrated BioPharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Integrated BioPharma figures

See a number that looks wrong?